Seattle, WA 98109-1024
United States
Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division
SARS-CoV-2, COVID-19, nanoluciferase, bioluminescence imaging, neutralizing antibodies, convalescent patients, human ACE2 transgenic mice, monocytes, natural killer cells, monocytes, pathogenesis, inflammatory cytokines, Fc effector functions